Form 4: Stepan Co Executive Receives Equity Compensation

Stepan Company VP and GM of Surfactants NA, Adriano Jose Galimberti Afonso, was granted performance shares, restricted stock units, and stock appreciation rights.

Summary

• Afonso Adriano Jose Galimberti, VP and GM of Surfactants NA, received a new equity compensation package on April 13, 2026.
• The grant includes 1,310 performance shares, 2,621 restricted stock units (RSUs), and 3,694 stock appreciation rights (SARs).
• Performance shares vest based on company performance goals through December 31, 2028.
• RSUs and SARs vest ratably over a three-year period starting April 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding routine executive compensation.

Positives

• Aligns executive compensation with long-term shareholder value through performance-based vesting.
• Retention of key leadership personnel through multi-year vesting schedules.

Negatives

• Potential for future share dilution upon the vesting and conversion of these equity instruments.

Risks

• Performance shares are contingent upon meeting specific company goals, which may not be achieved.
• Market volatility could impact the value of the stock appreciation rights.

Future Outlook

The equity grants are designed to incentivize performance through 2028 and ensure executive retention through 2029.

Management Comments

• The filing does not contain narrative management commentary.

Industry Context

StockSavvy.ai notes that this is a standard regulatory disclosure for executive compensation, reflecting typical corporate governance practices in the chemical manufacturing sector.

Comparison to Industry Standards

• The use of performance shares and RSUs is consistent with standard executive compensation packages at mid-cap chemical companies.
• Vesting schedules of three years are standard practice for retaining senior management in the specialty chemicals industry.

Stakeholder Impact

• Shareholders should note the potential for future dilution as these equity awards vest.

Next Steps

• Monitor future proxy statements for details on performance goal achievement.
• Track vesting dates for potential impact on share count.

Key Dates

Keywords

Stepan Company, SCL, Form 4, Insider Trading, Executive Compensation, Equity Grant